Literature DB >> 20847653

Ocular involvement in chronic graft-versus-host disease: therapeutic approaches to complicated courses.

Konrad R Koch1, Antonia M Joussen, Klaudia K Huber.   

Abstract

Chronic graft-versus-host disease (cGvHD) is a major concomitant phenomenon in recipients of allogeneic hematopoietic stem cell transplantations, affecting multiple organ systems including the eye. Ocular structures, such as lacrimal gland, conjunctiva, and eyelids with meibomian glands, are frequently involved with clinical features ranging from dry eyes and common inflammatory conjunctival disease to severe complications like corneal ulcerations or even perforations. We present 2 patients with complicated courses of ocular cGvHD. In both cases, keratoconjunctivitis sicca refractory to systemic immunosuppressive therapy and to conventional topical treatment resulted in progressive binocular corneal melting and finally repeated perforations. According to our 2 cases and to the current pathophysiological understanding, we discuss possible strategies for the treatment and prevention of ocular cGvHD complications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20847653     DOI: 10.1097/ICO.0b013e3181e2ecf0

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease.

Authors:  Jianyu Weng; Chang He; Peilong Lai; Chenwei Luo; Rong Guo; Suijing Wu; Suxia Geng; Andy Xiangpeng; Xialin Liu; Xin Du
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

Review 2.  Graft versus host disease: clinical evaluation, diagnosis and management.

Authors:  Edgar M Espana; Sejal Shah; Marcony R Santhiago; Arun D Singh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-17       Impact factor: 3.117

3.  Toll-like receptor 2-mediated NF-κB inflammatory responses in dry eye associated with cGVHD.

Authors:  Chang He; Peilong Lai; Jianyu Weng; Shaoze Lin; Kaili Wu; Xin Du; Xialin Liu
Journal:  Mol Vis       Date:  2011-10-05       Impact factor: 2.367

Review 4.  Mesenchymal stem cells for treating autoimmune dacryoadenitis.

Authors:  Xiaoxiao Lu; Xilian Wang; Hong Nian; Dan Yang; Ruihua Wei
Journal:  Stem Cell Res Ther       Date:  2017-06-05       Impact factor: 6.832

5.  A case of severe dry eye disease with corneal melting as presenting complaint of acute myeloid leukaemia.

Authors:  Dmitri Pchejetski; Heba Alshaker; Radomir Babovic; Kyaw Maw
Journal:  SAGE Open Med Case Rep       Date:  2021-02-12

Review 6.  Mesenchymal stem cells for treating ocular surface diseases.

Authors:  Liyun Zhang; Vivien Jane Coulson-Thomas; Tarsis Gesteira Ferreira; Winston W Y Kao
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.